Table 2.
Immune-Modulatory Approach | Mechanism |
---|---|
Inhaled corticosteroid | ECM deposition↓ |
EMT↓ | |
Inflammatory cell infiltration↓ | |
Macrolide | Inflammatory cascade↓ |
Adhesion molecule expression↓ | |
Neutrophil chemotaxis and activation↓ | |
Monocyte-macrophage differentiation↓ | |
Fluoroquinolones | NF-κB activation↓ |
Ceftaroline | TLR expression↓ |
Vitamin D receptor | Retain phagocytic capacity |
NF-κB and p38 MAPK cascade↓→ MMPs and TGF-β ↓ → airway wall destruction↓ fibrotic repair↓ | |
Antibodies of pro-inflammatory cytokines | IL-4, IL-5, IL-13, and IgE↓ |
Notes: ↑, increased during COPD progression; ↓, decreased during COPD progression; (-), no change during COPD progression.
Abbreviations: ECM, extracellular matrix; EMT, epithelial-mesenchymal transition; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; TLR, toll-like receptors; p38 MAPK, p38 mitogen-activated protein kinase; MMPs, matrix metalloproteinases; TGF-β, transforming growth factor beta; IL, interleukin; IgE, immunoglobulin E.